warning about reports of acute renal failure with Immune Globulin Intravenous (IVIG) products

The FDA is now warning about reports of acute renal failure with Immune Globulin Intravenous (IVIG) products.

The risk appears to be highest with products that contain sucrose...Sandoglobulin, Panglobulin, and Gammar-P IV. These solutions can cause kidney damage due to their higher osmotic load.

Patients at increased risk are primarily those with pre-existing renal dysfunction...diabetes...and over 65.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote